Scientists identified a novel, highly specific drug target in the enzyme (sterol O-acyltransferase 1 (SOAT1)) cancer cells use to store cholesterol.
List view / Grid view
Pancreatic ductal adenocarcinoma (PDAC)
Filter the results
Researchers have developed a new cocktail of drugs that shrink pancreatic tumours in mice by blocking pathways that cancer cells use.
A protein that causes pancreatic ductal adenocarcinoma has been identified as a therapeutic target by researchers.
Scientists in California have discovered that a newly developed drug prevents pancreatic cancer in lab mice.
8 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Through a process involving vitamin A, researchers from Imperial College London observed that it was possible to switch off pancreatic stellate cells...